Congenital Neutropenia Due to G6pc3 Deficiency
📧 Sign up to get email alerts when something new happens for Congenital Neutropenia Due to G6pc3 Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency [Phase 1]
A Phase 1 clinical trial evaluating empagliflozin for severe congenital neutropenia due to G6PC3 deficiency has completed, per the NIAID-spo…